Megan Walker, Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 101 S Wall St, Carbondale, IL 62901 Phone: 618-519-9200 |
Gayla Joy Wayman, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 202 W Jackson St, Carbondale, IL 62901 Phone: 618-457-0465 Fax: 618-457-8022 |
Mrs. Elizabeth Anne Jolliff, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 101 S Wall St, Carbondale, IL 62901 Phone: 618-519-9200 Fax: 618-519-9404 |
Rachael Wernsman, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 101 S Wall St, Carbondale, IL 62901 Phone: 618-519-9200 Fax: 618-519-9961 |
Mrs. Jennifer Marie Shopinski, APN, CNM, IBCLC Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 202 W Jackson St, Carbondale, IL 62901 Phone: 618-457-0465 Fax: 618-457-8022 |
Jennifer Ting, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 101 S Wall St, Carbondale, IL 62901 Phone: 618-519-9200 Fax: 618-519-9404 |
News Archive
Calls to regionalize the care of patients with heart attacks are premature, and do not account for potential unintended consequences, according to a commentary by Yale researchers published in the Journal of the American Medical Association (JAMA).
An international team of Canadian and Spanish scientists have found the first potential immunological clue of why some people develop severe pneumonia when infected by the pandemic H1N1 virus.
New research shows that a less-toxic combination of a targeted immune-based drug and a chemotherapy drug can produce long-term remissions in some chronic lymphocytic leukemia patients. And it does so without increasing the risk of later therapy-related myelodysplastic syndrome and acute myeloid leukemia, which can often occur with a three-drug combination used to treat these patients.
A third of the global burden of disease for mental, neurological and substance use disorders occurs in India and China – more than in all high-income countries combined – yet most people with mental disorders in these countries do not receive needed treatment.
A new therapeutic being tested by University of Alberta researchers is showing early promise as a more effective treatment that could help nearly half of patients with Duchenne muscular dystrophy.
› Verified 4 days ago